Breakthrough findings on nanoparticle delivery of HIV/AIDS medications to brain

nanoparticles
Credit: CC0 Public Domain

A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems.

"While HIV can be managed as a chronic condition, current drugs cannot cross the ," said Shanta Dhar, Ph.D., associate professor of biochemistry and , and assistant director of technology and innovation at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. "Therefore, the ability of nanoparticles to deliver to the brain is a significant breakthrough that could potentially improve the treatment of brain cancers and other diseases."

For the past decade, Dr. Dhar has been studying a polymer chain nanoparticle as a vehicle for intracellular delivery. Her latest laboratory study, "Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress," was published recently in the American Chemical Society journal, ACS Nano.

Miller School co-authors were Bapurao Surnar, Ph.D; Anuj S. Shah; Minseon Park, Ph.D; Akil A. Kalathil; Mohammad Z. Kamra, Ph.D.; and Michal Toborek, M.D., Ph.D. The research team included Nagesh Kolishetti, Ph.D., as a corresponding author; his student, Royden Ramirez Jaime; and Madhavan Nair, Ph.D.; all from the Herbert Wertheim College of Medicine, Florida International University.

Drs. Dhar and Kolishetti said, "Using an experimental model, we were able to use biodegradable brain-targeted polymeric nanoparticles to reduce the HIV/AIDS viral burden. We also included antioxidant and anti-inflammatory neuroprotectants to address stress and inflammation in the brain cells."

Dr. Dhar noted that nanoparticle drug delivery offers a new strategy for treating HIV-associated neurocognitive disorders, such as HIV dementia, which can be magnified by recreational drug use in HIV-positive individuals. She added, "Looking ahead, this therapeutic strategy, which we have demonstrated in our laboratory, has great potential for improving treatment of a wide range of brain diseases."

More information: Bapurao Surnar et al, Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress, ACS Nano (2021). DOI: 10.1021/acsnano.0c09553

Journal information: ACS Nano

Citation: Breakthrough findings on nanoparticle delivery of HIV/AIDS medications to brain (2021, August 11) retrieved 27 September 2023 from https://phys.org/news/2021-08-breakthrough-nanoparticle-delivery-hivaids-medications.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

A Trojan horse could help get drugs past our brain's tough border patrol

467 shares

Feedback to editors